| 000 | 01548 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513060613.0 | ||
| 264 | 0 | _c19941006 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0195-668X | ||
| 024 | 7 |
_a10.1093/eurheartj/15.suppl_b.2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoyé, L A | |
| 245 | 0 | 0 |
_aUniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cMay 1994 |
||
| 300 |
_a2-8; discussion 26-30 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCaptopril _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xdrug therapy |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aPfeffer, M A | |
| 700 | 1 | _aWun, C C | |
| 700 | 1 | _aDavis, B R | |
| 700 | 1 | _aGeltman, E | |
| 700 | 1 | _aHayes, D | |
| 700 | 1 | _aFarnham, D J | |
| 700 | 1 | _aRandall, O S | |
| 700 | 1 | _aDinh, H | |
| 700 | 1 | _aArnold, J M | |
| 773 | 0 |
_tEuropean heart journal _gvol. 15 Suppl B _gp. 2-8; discussion 26-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/15.suppl_b.2 _zAvailable from publisher's website |
| 999 |
_c8075983 _d8075983 |
||